# SERPINC1 mutations and thrombotic events in inherited antithrombin deficiency: a study on the han population of East China

## TL;DR

This study identifies SERPINC1 gene mutations in a Chinese population with inherited antithrombin deficiency and explores their link to thrombosis.

## Contribution

The study characterizes novel SERPINC1 mutations in a Chinese cohort and links them to thrombophilia mechanisms.

## Key findings

- Most probands had type I or type II antithrombin deficiency, with mutations primarily in exons 5 and 3.
- Recurrent missense mutations c.1346T > A and c.442T > C were identified, with high heterogeneity observed.
- In vitro analysis confirmed that synthesis and secretion defects in mutant proteins cause antithrombin deficiency.

## Abstract

Inherited antithrombin deficiency (ATD), a rare autosomal dominant disorder due to SERPINC1 gene mutations, is the most severe inherited thrombophilia. Limited literature exists that focuses on ATD and its mutations in the Chinese population. This study aimed to characterize SERPINC1 gene mutations in a Chinese cohort and to explore their relationship with thrombophilia.

Coagulation screening results and clinical data were meticulously collected from 23 unrelated probands with ATD and their family members. Genomic DNA was extracted and subjected to PCR amplification and direct sequencing. Putative mutations were analyzed using in silico bioinformatic tools. Mutant antithrombin (AT) proteins were expressed in HEK293 cells, and ELISA was used to detect wild-type and mutant AT. RT-qPCR was used to measure AT mRNA expression in transfected cells.

Among the 23 probands, 15 (65.2%) exhibited concurrent reductions in both AT: A and AT: Ag (type I defects), while the remaining 8 (34.8%) had normal AT: Ag levels (type II defects). Genetic analysis revealed a spectrum of 21 distinct mutations across 87.0% (20/23) of the probands. Most were point mutations predicted to be deleterious and were primarily located in exons 5 and 3. Among the 20 mutation carriers, 15 (75%) were heterozygous and most of them experienced thrombosis with identifiable triggers. The other 5 (25%) were compound heterozygous and primarily presented with spontaneous thrombosis. Notably, the missense mutations c.1346T > A and c.442T > C were recurrent. These mutations exhibited high heterogeneity, with no ethnic-specific mutations observed. In vitro expression confirmed that synthesis and/or secretion defects in the mutant proteins are the primary mechanism underlying the antithrombin deficiency.

SERPINC1 gene analysis benefits asymptomatic family members, especially child-bearing women, by informing venous thromboembolism prevention strategies and guiding anticoagulant choice in cases involving heparin-binding site mutations. This underscores the essential role of genetic diagnosis in ATD management.

The online version contains supplementary material available at 10.1186/s13023-026-04200-0.